Novel therapy appears to be a promising tool for hair growth promotion, an expert says.
Ilya Petrou, M.D.
A recent study showed that individuals with darker skin appear to have greater chronic subclinical inflammation in the stratum corneum, compared to those with lighter skin.
A recent trial with etanercept proved largely ineffective in the treatment of hidradenitis suppurativa.
According to one expert, a gluten-free diet is the best approach to treating dermatitis herpetiformis.
Psoriasis and metabolic syndrome seem to be increasingly related disease entities.
According to one expert, experience plays a major role in the mastery of laser surgery, especially for physicians who are just learning to use these devices.
Portland, Ore. — A recent study confirms that the numbers of follicular melanocytes are significantly decreased in patients suffering from alopecia areata.
This new insight into the often severe and psychologically burdensome disease serves as a beacon of hope for patients, as researchers begin to home in on a more precise etiology that may open the door for more targeted treatments. Past research has implicated follicular melanocytes to be the target structure in at least a proportion of patients suffering from alopecia areata.
New York — Cosmetic patients today have a multitude of cosmeceuticals from which to choose, and each product claims to raise the bar in its effectiveness in skin rejuvenation. Many of these products do have some degree of effectiveness, and yet others may be the cause of hardship in terms of eliciting an irritant or allergic contact dermatitis in the unfortunate user. According to one expert, physicians need to scrutinize the ingredients of these cosmeceuticals and carefully pick and choose among the vast array of products for the benefit of their patients.
Edmonton, Alberta — Although several different theories exist with regard to the pathogenesis of vitiligo, an immune basis appears to be the most favored mechanism, with cytokines and other chemical mediators playing a center role in disease development and progression. As a result, immunomodulating therapies such as tacrolimus (Protopic, Astellas) are employed.
’Crystel’ clear: Study shows etanercept improves depression, anxiety in psoriasis patients
International report — Etanercept therapy helps to improve symptoms of depression and anxiety long-term in patients suffering from moderate-to severe psoriasis, according to the results of the Crystel study.